knowledge -WSS

knowledge

author：focus 2025-09-28 09:21:23 - browse：15

TALLINN, Estonia -- A Belarusian journalist was sentenced Friday to four years in prison after being convicted of aiding extremist activities as the authoritarian country continues a severe crackdown on the opposition and independent reporting.

The trial of video journalist Pavel Padabed was held behind closed doors. His conviction and sentencing were reported by the Belarusian Association of Journalists.

Padabed worked with Belsat, a Polish-funded satellite channel that broadcasts into Belarus and is considered by the Belarusian government to be “extremist media.”

The journalists' association said material presented at his trial included investigative programs about the disappearance of a videographer and the 2016 car bombing in Ukraine of TV journalist Pavel Sharemet.

Belarus President Alexander Lukashenko, in power since 1994, has taken an increasingly repressive line toward the opposition and independent journalists since mass protests engulfed the country in 2020 following a presidential election that gave him a sixth term in office but was widely regarded as fraudulent.

The journalists' association says 34 journalists are currently behind bars.

More than 35,000 people were arrested during the 2020 protests, and many were severely beaten by police. The Belarusian human rights group Viasna says there are nearly 1,500 political prisoners in the country.

Exiled opposition leader Sviatlana Tsikhanouskaya, who ran against Lukashenko in 2020, met Friday with European Council President Charles Michel and EU foreign policy chief Josep Borrell.

Afterward, the European Council issued a statement calling on Belarus to stop allowing Russia to base troops there for use in the war in Ukraine and end the deployment there of Russian tactical nuclear weapons.

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： UCB departs biotech trade group BIO

focus

WSS

The biotech scorecard for Q1: 17 stock

Paxlovid rebound happens. Why and to whom are still a mystery

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

Sage considers ways to reduce costs following FDA rejection

Sweden knocks USA out of World Cup in penalty kicks

The biotech scorecard for Q1: 17 stock

focus

knowledge

leisure time

FDA approval of Sarepta Duchenne genetic therapy gives me hope

AdventHealth escalates lawsuit against insurance vendor Multiplan

DIEP, the 'gold standard' of breast reconstruction, is under threat

Ahead of JPM, here's who's profiting most in health care

Affirmative action in medical school literally saved lives

Failure, not just success, should guide future doctors

How to save PrEP access — and even expand it

JPM: CVS says Medicare Advantage patients are impacting profits

FDA approval of Sarepta Duchenne genetic therapy gives me hope

GSK Flovent asthma inhalers replaced by authorized generics

explore

Kansas bar where gunfire wounded 9 last month closes permanently

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

Feed a cold, starve a fever? Here’s what science says

Judge in Trump's classified documents case questions use of out

Videos point to link between seizures and unexplained toddler deaths

Mexico finds 491 migrants being held at vacant lot, almost all are from Guatemala

focus

hotspot

hotspot

focus